Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. LCT1U6PSXBLUEX2 (U.S. Pat. App. Jan. 11, 2023)
Cite Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. LCT1U6PSXBLUEX2 (U.S. Pat. App. Jan. 11, 2023)
+ More Snippets
Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. L5IEJL7YGREENX5 (U.S. Pat. App. Jul. 12, 2022)
Cite Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. L5IEJL7YGREENX5 (U.S. Pat. App. Jul. 12, 2022)
+ More Snippets
Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. L5IEJL7XGREENX5 (U.S. Pat. App. Jul. 12, 2022)
Cite Document
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS, 16/397,267, No. L5IEJL7XGREENX5 (U.S. Pat. App. Jul. 12, 2022)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 28 (N.D.W.Va. Dec. 8, 2023)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 28 (N.D.W.Va. Dec. 8, 2023)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 25 (N.D.W.Va. Dec. 8, 2023)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 25 (N.D.W.Va. Dec. 8, 2023)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 74 (N.D.W.Va. Jan. 24, 2024)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 74 (N.D.W.Va. Jan. 24, 2024)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 76 (N.D.W.Va. Jan. 25, 2024)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 76 (N.D.W.Va. Jan. 25, 2024)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 79 (N.D.W.Va. Jan. 25, 2024)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 79 (N.D.W.Va. Jan. 25, 2024)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 71 (N.D.W.Va. Jan. 22, 2024)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 71 (N.D.W.Va. Jan. 22, 2024)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 68 (N.D.W.Va. Jan. 17, 2024)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 68 (N.D.W.Va. Jan. 17, 2024)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 35 (N.D.W.Va. Dec. 14, 2023)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 35 (N.D.W.Va. Dec. 14, 2023)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 34 (N.D.W.Va. Dec. 14, 2023)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 34 (N.D.W.Va. Dec. 14, 2023)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 31 (N.D.W.Va. Dec. 12, 2023)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 31 (N.D.W.Va. Dec. 12, 2023)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 85 (N.D.W.Va. Jan. 31, 2024)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 85 (N.D.W.Va. Jan. 31, 2024)
+ More Snippets
Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 65 (N.D.W.Va. Jan. 11, 2024)
Cite Document
Regeneron Pharmaceuticals, Inc. v. Celltrion, Inc., 1:23-cv-00089, No. 65 (N.D.W.Va. Jan. 11, 2024)
+ More Snippets